Xylem Inc (NYSE:XYL) reported upbeat earnings for the fourth quarter on Tuesday.

The company posted quarterly earnings of $1.42 per share which beat the analyst consensus estimate of $1.41 per share. The company reported quarterly sales of $2.397 billion which beat the analyst consensus estimate of $2.374 billion.

Xylem said it sees FY2026 adjusted EPS of $5.35-$5.56, versus market estimates of $5.56. The company sees sales of $9.100 billion-$9.200 billion, versus expectations of $9.331 billion.

“The team delivered an exceptionally strong fourth quarter, capping a year of solid execution and transformation across Xylem,” said Matthew Pine, Xylem’s CEO. “We achieved record full-year revenue, adjusted EBITDA margin, and adjusted EPS, supported by broad-based demand across our largest end markets. Healthy organic revenue and orders growth gave us solid momentum coming into 2026.”

Xylem shares dipped 2.1% to trade at $126.24 on Wednesday.

These analysts made changes to their price targets on Xylem following earnings announcement.

• Barclays analyst William Grippin maintained Xylem with an Overweight rating and lowered the price target from $166 to $156.
• RBC Capital analyst Deane Dray maintained the stock with an Outperform rating and lowered the price target from $176 to $162.

Considering buying XYL stock? Here’s what analysts think:

Photo via Shutterstock